Holiday Entertaining 2016: Award-Winning Hiro® Sake From Japan Celebrates its Fifth Anniversary and Presents New Portfolio Addition, Hiro Gold

Hiro Launches In Canada, With Extended Distribution in the United States…. And More to Come.

Hiro Sake®, the award-winning, handcrafted, premium sake from Japan, is celebrating its fifth anniversary with a series of exciting new developments. The company—which has grown in sales for each of its five years—having put the finishing touches on its most luxurious and high-end sake ever, is expanding into British Columbia and has broadened its reach across the United States.

Japanese Sake dates back to over 2,000 years ago, even before the first Japanese written books ever recorded… Lore has it that Japanese Sake’s origin occurred when some natural airborne yeast landed in an open container of rice producing a slightly fermented liquid that gave some lucky farmers a pleasant buzz. Japanese Sake gained the favor of the Japanese Imperial Court, which formed its own brewing department.

The magic of Japanese Sake lies in its extreme versatility. It is said that Japanese Sake is made like a beer but drinks like a wine. To be accurate, Japanese Sake is its own category of alcoholic beverage and its affinity for food spans the beer-to-wine spectrum. It has become so much more than a drink to be served ‘chilled’ or warm with Japanese food. Now, Japanese Sake is a gourmet addition to any dinner table and can be enjoyed paired with cheese, chocolate, and all varieties of ethnic foods. Japanese Sake can also be used in an infinite number of cocktails, usually standing in for white spirits such as vodka, rum or gin and with only half the alcohol of traditional spirits.

To expand its portfolio of fine sakes, Hiro Sake presents Hiro Gold, an ultra-premium sake known as Junmai Daiginjo sake, a product crafted from 100% Koshi-Tanrei sake rice. This rice is grown exclusively in the Niigata Prefecture, the premier sake producing region in Japan, where all Hiro Sake is brewed. Hiro Gold is produced in limited quantities only once a year by Hiro’s Toji (Sake Master) and will be available initially in California, Florida, New York and Texas with a suggested retail price of $100.00 (15% alc./vol.; 720ml).


Award-winning HIRO GOLD Junmai Daiginjo SAKE from Japan arrives in the U.S. this month.

Hiro Gold was also the recent winner of a Double Gold Medal at the 2016 San Francisco International Wine Competition and joins the portfolio of Hiro Blue and Hiro Red. In 2011 Hiro’s Toji was awarded first prize in a Japanese national sake competition, regarded as one of the most important sake competitions in the world. In addition to the 2016 Double Gold Medal awarded to Hiro Gold at the San Francisco International Wine Competition, Hiro Sake has won additional accolades from the same competition including a Double Gold Medal for Hiro Blue (2015) and named ‘BEST OF NATION‘ from Japan, the highest award bestowed. Hiro is imported by Hiro Sake USA in Manhasset, NY.


In addition to the new Hiro Gold Junmai Daiginjo, Hiro offers Hiro Blue junmai ginjo (15% ABV) and Hiro Red ginjo (15% ABV).

Hiro is hand crafted Japanese sake using only the finest ingredients at the Brewery Taiyo Shuzo, established in 1635 in the Niigata Prefecture, long considered one of the finest craft sake breweries in Japan. In addition to the new Hiro Gold Junmai Daiginjo, Hiro offers Hiro Blue junmai ginjo (15% ABV) and Hiro Red ginjo (15% ABV). Hiro Red and Hiro Blue can be used in an infinite number of cocktails, standing in for vodka, rum or gin and with only half the alcohol of traditional spirits. Hiro is only 39 calories/ounce, additive- and preservative-free, gluten-free (made with rice), histamine- and allergen-free (no allergic reactions) and has 1/3 the acidity of wine (making it easier on the stomach). Continue reading

Dog-Loving Clothing Brand, Antonio Stefano, Makes Its World Debut on the Catwalks of Fashion Week Los Angeles Monday, October 17th

Antonio Stefano, the LA/Milan-based fashion brand that loves dogs is launching its collection with Italian hand-made silk ties on Monday at Fashion Week Los Angeles, followed by an afterparty at the W Hotel in Hollywood. The brand is donating 49% of its profits towards building a dog hospital that supports abused and abandoned dogs.428941

Devoting a full 49% of its profits towards abused dogs, the high-end clothing brand Antonio Stefano is probably the world’s most cause-related company. Stefano Riznyk, the Chief Creative Director, felt a strong need for unique ties as a starting point. As a business lawyer and high-level negotiator, he is often wearing ties, and feels the market is flooded with ties that don’t speak reflect the person wearing it.

For Mr. Riznyk, there are only three ways a man can distinguish himself: his tie, watch, and belt; anything else other and he risks losing the respect of the mainstream in the high-stakes business world. A tie, however, can separate someone from the pack. It is so much more than an accessory, it is a statement.

With 20 ties in the collection at, they range in price from $69 to $225 and each is hand-made in Italy, using the finest Italian silk. Each has its own unique story, so that customers can understand the inspiration behind each tie. Each design is original and a tie can take up to two months of back and forth between Riznyk and his Italian team to design. Once hand painted, the designs are digitized and go into production, and then shipped to the operations facilities in San Diego.

Antonio Stefano has a unique slogan: Size Does Not Matter, Fit Does. It explains the fact that each tie is available in 3 sizes: the standard 58″ by 3.5″, a shorter version at 55″, and a taller version that is 6″ longer than the standard. The sizes are appropriately named: Tall, Taller, and Tallest. They are both printed and manufactured in the same companies as you will find the world’s top ten designers making theirs.

The fashion show will also offer a sneak peak at the next line, a stunning Jaguar-designed women’s bathrobe that will be made of either silk or satin, depending on market forces. The first of ten models at the show will offer a sneak peak into the next item in production, a silk or satin (your choice) bathrobe in a dazzling jaguar design to replace the ‘grandmotherly’ bathrobes that women now have to use when courting their new man.

New CDC Study Shows Changes In Breast Cancer Death Rates By Age Group

Corresponding author: Lisa C. Richardson,

Breast cancer death rates among women decreased during 2010-2014, but racial differences persisted, according to a study by the Centers for Disease Control and Prevention (CDC) in this week’s Morbidity and Mortality Weekly Report.cdc-logo1

Breast cancer continues to be the most commonly diagnosed cancer and the second leading cause of cancer deaths among U.S. women (1). Compared with white women, black women historically have had lower rates of breast cancer incidence and, beginning in the 1980s, higher death rates (1). This report examines age-specific black-white disparities in breast cancer incidence during 1999–2013 and mortality during 2000–2014 in the United States using data from United States Cancer Statistics (USCS) (2). Overall rates of breast cancer incidence were similar, but death rates remained higher for black women compared with white women. During 1999–2013, breast cancer incidence decreased among white women but increased slightly among black women resulting in a similar average incidence at the end of the period. Breast cancer incidence trends differed by race and age, particularly from 1999 to 2004–2005, when rates decreased only among white women aged ≥50 years. Breast cancer death rates decreased significantly during 2000–2014, regardless of age with patterns varying by race. For women aged ≥50 years, death rates declined significantly faster among white women compared with black women; among women aged <50 years, breast cancer death rates decreased at the same rate among black and white women. Although some of molecular factors that lead to more aggressive breast cancer are known, a fuller understanding of the exact mechanisms might lead to more tailored interventions that could decrease mortality disparities. When combined with population-based approaches to increase knowledge of family history of cancer, increase physical activity, promote a healthy diet to maintain a healthy bodyweight, and increase screening for breast cancer, targeted treatment interventions could reduce racial disparities in breast cancer.

USCS includes incidence data from the CDC’s National Program of Cancer Registries (NPCR) and the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Program and mortality data from the National Vital Statistics System (2). Data on new cases of invasive (malignant) breast cancer* diagnosed during 1999–2013 were obtained from population-based cancer registries affiliated with NPCR or SEER programs in each state and the District of Columbia (DC). Incidence data in this report met USCS publication criteria, covering 99% of the U.S. population during 2009–2013 and 92% during 1999–2013.† SEER Summary Stage 2000§ was used to characterize cancers as localized, regional, distant, or unknown stage using clinical and pathologic tumor characteristics, such as tumor size, depth of invasion and extension to regional or distant tissues, involvement of regional lymph nodes, and distant metastases. Breast cancer death data during 2000–2014 were based on death certificate information reported to state vital statistics offices and compiled into a national file through the National Vital Statistics System; mortality data in this report cover 100% of the U.S. population. Race and ethnicity were abstracted from medical records for cases and from death certificates for deaths; this report includes all races, white, and black, regardless of ethnicity. Population estimates for the denominators of incidence and death rates were from the U.S. Census, as modified by the National Cancer Institute. Five-year average annual incidence rates for 2009–2013 and death rates for 2010–2014 per 100,000 women were age-adjusted by the direct method to the 2000 U.S. standard population (19 age groups).¶ Average annual percentage change was used to quantify changes in incidence rates during 1999–2013 and death rates during 2000–2014 and was calculated using joinpoint regression, which allowed different slopes for three periods; the year at which slopes changed could vary by race and age.

During 2009–2013, approximately 221,000 breast cancers were diagnosed each year (Table). Overall incidence of breast cancer was similar among black women (121.5 cases per 100,000 population) and white women (123.6 cases per 100,000 population), but differences by age and stage were found. Compared with white women, breast cancer incidence was higher among black women aged <60 years, but lower among black women aged ≥60 years. Black women had a lower percentage of breast cancers diagnosed at a localized stage (54%) than did white women (64%) (Table). Among white women, breast cancer incidence decreased from 1999 to 2004, and then stabilized, decreasing 0.8% per year on average; however, breast cancer incidence was stable from 1999 to 2005 among black women and then nonsignificantly increased (Figure 1). Breast cancer incidence trends differed by race and age, particularly during 1999–2004 when rates decreased only among white women aged ≥50 years. During 1999–2013, among women aged 60–79 years, rates of breast cancer incidence decreased significantly among white women, but increased significantly among black women (


Figure 1: Trends* in invasive female breast cancer incidence, by race† and year of diagnosis — United States,§ 1999–2013 (CDC/MMWR, October 14, 2016)

During 2010–2014, approximately 41,000 deaths from breast cancer occurred each year (Table). Breast cancer mortality was 41% higher among black women (29.2 deaths per 100,000 population) than white women (20.6 deaths per 100,000 population). Breast cancer death rates decreased during 2010–2014 among both blacks and whites, although differences in trends by race and age were found (Figure 2). Overall, breast cancer death rates decreased faster among white women (−1.9% per year) compared with black women (−1.5% per year). Among women aged <50 years, breast cancer death rates decreased at the same pace among black and white women, whereas white women aged ≥50 years had significantly larger decreases. The largest difference by race was observed among women aged 60–69 years: breast cancer death rates decreased 2.0% per year among white women compared with 1.0% among black women.


FIGURE 2. Average annual percentage change* in female breast cancer death rates, by age group and race† — United States, 2000–2014 (CDC/MMWR October 14, 2016)


Recent trends in breast cancer incidence suggest that the convergence and now equal incidence for black and white women has been primarily because of incidence increasing among black women, particularly among those aged 60–79 years, and concomitant decreasing or stable rates in white women. Breast cancer mortality is approximately 40% higher among black women compared with white women, with faster decreases in mortality among white women. This report confirms previous findings by race overall (1), and presents age-specific changes for incidence and mortality by race. Continue reading